SCHEMBL6133434

SCHEMBL6133434

Cn1nc(-c2sc(C(=O)NC3CC3)nc2-c2ccccc2)ccc1=O

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.46
HTT P42858 3/20 0.46
MAPT P10636 2/20 0.46
CNR1 P21554 3/20 0.43
MAOB P27338 1/20 0.42
KDM4E B2RXH2 1/20 0.40
MAPK1 P28482 1/20 0.40
KAT2B Q92831 1/20 0.40
PIN1 Q13526 3/20 0.39
CNR2 P34972 2/20 0.39
LMNA P02545 1/20 0.39
MAPK8 P45983 1/20 0.39
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
NPC1 O15118 1/20 0.39
RAB9A P51151 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
PDE10A Q9Y233 2/20 0.39
AURKA O14965 1/20 0.38
CCNA2 P20248 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6133697 0.87 HSD17B10 (0.46) ALDH1A1HTTMAPTCNR1KDM4E
SCHEMBL6133518 0.87 USP2 (0.46) ALDH1A1HTTMAPTCNR1MAOB
SCHEMBL6133760 0.87 MAOB (0.40) ALDH1A1HTTCNR1MAOBCNR2
SCHEMBL6828616 0.86 USP2 (0.43) ALDH1A1HTTMAPTCNR1KDM4E
SCHEMBL6133653 0.84 ALDH1A1 (0.54) ALDH1A1MAPTCNR1MAOBMAPK1
SCHEMBL6133513 0.83 ALDH1A1 (0.46) ALDH1A1HTTMAPTKDM4EMEN1
SCHEMBL6133470 0.83 ALDH1A1 (0.47) ALDH1A1HTTMAPTKDM4E
SCHEMBL6920286 0.82 HTT (0.43) ALDH1A1HTTMAPTCNR1MAOB
SCHEMBL6133631 0.82 MAOB (0.47) ALDH1A1HTTMAPTCNR1MAOB
SCHEMBL6133994 0.82 ALDH1A1 (0.46) ALDH1A1HTTMAPTKDM4ENPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050004134-A1 Thiazole derivative and pharmaceutical use thereof ASTELLAS PHARMA INC. (JP) 2005-01-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050004134-A1 Thiazole derivative and pharmaceutical use thereof MC2R, CYP2C9, OXTR ALDH1A1 630/4885HTT 477/4885MAPT 3008/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.